[1]
A. Macas and G. Zinkevičiūtė-Žarskienė, “Acute heart failure: vasoactive agents – does it matter?”, AML, vol. 19, no. 3, pp. 215–219, Oct. 2012, doi: 10.6001/actamedica.v19i3.2453.